|
1
|
Zhang D and Fan D: New insights into the
mechanisms of gastric cancer multidrug resistance and future
perspectives. Future Oncol. 6:527–537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kathawala RJ, Gupta P, Ashby CR Jr and
Chen ZS: The modulation of ABC transporter-mediated multidrug
resistance in cancer: A review of the past decade. Drug Resist
Updat. 18:1–17. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Holohan C, Van Schaeybroeck S, Longley DB
and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat
Rev Cancer. 13:714–726. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yook SH, Oltvai ZN and Barabási AL:
Functional and topological characterization of protein interaction
networks. Proteomics. 4:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barabási AL and Oltvai ZN: Network
biology: Understanding the cell's functional organization. Nat Rev
Genet. 5:101–113. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Desmedt C, Di Leo A, de Azambuja E,
Larsimont D, Haibe-Kains B, Selleslags J, Delaloge S, Duhem C,
Kains JP, Carly B, et al: Multifactorial approach to predicting
resistance to anthracyclines. J Clin Oncol. 29:1578–1586. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferriss JS, Kim Y, Duska L, Birrer M,
Levine DA, Moskaluk C, Theodorescu D and Lee JK: Multi-gene
expression predictors of single drug responses to adjuvant
chemotherapy in ovarian carcinoma: Predicting platinum resistance.
PLoS One. 7:e305502012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Agostini M, Zangrando A, Pastrello C,
D'Angelo E, Romano G, Giovannoni R, Giordan M, Maretto I, Bedin C,
Zanon C, et al: A functional biological network centered on XRCC3:
A new possible marker of chemoradiotherapy resistance in rectal
cancer patients. Cancer Biol Ther. 16:1160–1171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A,
Michalowski A and Green JE: A gene expression signature of acquired
chemoresistance to cisplatin and fluorouracil combination
chemotherapy in gastric cancer patients. PLoS One. 6:e166942011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bindea G, Mlecnik B, Hackl H, Charoentong
P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z and
Galon J: ClueGO: A Cytoscape plug-in to decipher functionally
grouped gene ontology and pathway annotation networks.
Bioinformatics. 25:1091–1093. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bindea G, Galon J and Mlecnik B: CluePedia
Cytoscape plugin: Pathway insights using integrated experimental
and in silico data. Bioinformatics. 29:661–663. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du X, Zhao YP, Zhang TP, Zhou L, Chen G,
Wang TX, You L and Shu H: Alteration of the intrinsic apoptosis
pathway is involved in Notch-induced chemoresistance to gemcitabine
in pancreatic cancer. Arch Med Res. 45:15–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grossi V, Peserico A, Tezil T and Simone
C: p38α MAPK pathway: A key factor in colorectal cancer therapy and
chemoresistance. World J Gastroenterol. 20:9744–9758. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan J, Yin Z, Tao K, Wang G and Gao J:
Function of insulin-like growth factor 1 receptor in cancer
resistance to chemotherapy. Oncol Lett. 15:41–47. 2018.PubMed/NCBI
|
|
18
|
Bystrykh L, Weersing E, Dontje B, Sutton
S, Pletcher MT, Wiltshire T, Su AI, Vellenga E, Wang J, Manly KF,
et al: Uncovering regulatory pathways that affect hematopoietic
stem cell function using ‘genetical genomics’. Nat Genet.
37:225–232. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schadt EE, Lamb J, Yang X, Zhu J, Edwards
S, Guhathakurta D, Sieberts SK, Monks S, Reitman M, Zhang C, et al:
An integrative genomics approach to infer causal associations
between gene expression and disease. Nat Genet. 37:710–717. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Y, Han L, Yuan Y, Li J, Hei N and
Liang H: Gene co-expression network analysis reveals common
system-level properties of prognostic genes across cancer types.
Nat Commun. 5:32312014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marin JJ, Briz O, Monte MJ, Blazquez AG
and Macias RI: Genetic variants in genes involved in mechanisms of
chemoresistance to anticancer drugs. Curr Cancer Drug Targets.
12:402–438. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Delitto D, Vertes-George E, Hughes SJ,
Behrns KE and Trevino JG: c-Met signaling in the development of
tumorigenesis and chemoresistance: Potential applications in
pancreatic cancer. World J Gastroenterol. 20:8458–8470. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S,
Wu GS and Wu K: Notch signaling: An emerging therapeutic target for
cancer treatment. Cancer Lett. 369:20–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sui X, Kong N, Ye L, Han W, Zhou J, Zhang
Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of
apoptosis and autophagy in response to chemotherapeutic agents.
Cancer Lett. 344:174–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Racioppi L: CaMKK2: A novel target for
shaping the androgen-regulated tumor ecosystem. Trends Mol Med.
19:83–88. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin F, Marcelo KL, Rajapakshe K, Coarfa C,
Dean A, Wilganowski N, Robinson H, Sevick E, Bissig KD, Goldie LC,
et al: The camKK2/camKIV relay is an essential regulator of hepatic
cancer. Hepatology. 62:505–520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buemi M, Caccamo C, Nostro L, Cavallaro E,
Floccari F and Grasso G: Brain and cancer: The protective role of
erythropoietin. Med Res Rev. 25:245–259. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wyman SK, Knouf EC, Parkin RK, Fritz BR,
Lin DW, Dennis LM, Krouse MA, Webster PJ and Tewari M:
Post-transcriptional generation of miRNA variants by multiple
nucleotidyl transferases contributes to miRNA transcriptome
complexity. Genome Res. 21:1450–1461. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sepulveda JL and Wu C: The parvins. Cell
Mol Life Sci. 63:25–35. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Garrisi VM, Strippoli S, De Summa S, Pinto
R, Perrone A, Guida G, Azzariti A, Guida M and Tommasi S: Proteomic
profile and in silico analysis in metastatic melanoma with and
without BRAF mutation. PLoS One. 9:e1120252014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun D, Liu Y, Zhang XS and Wu LY: CEA:
Combination-based gene set functional enrichment analysis. Sci Rep.
8:130852018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Witsch E, Sela M and Yarden Y: Roles for
growth factors in cancer progression. Physiology (Bethesda).
25:85–101. 2010.PubMed/NCBI
|
|
34
|
Sun J, Feng C, Liao W, Zhang H and Tang S:
Expression of CXC chemokine receptor-4 and forkhead box 3 in
neuroblastoma cells and response to chemotherapy. Oncol Lett.
7:2083–2088. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang H, Zhang C and Cui S: Expression of
hepatocyte growth factor in breast cancer and its effect on
prognosis and sensitivity to chemotherapy. Mol Med Rep.
11:1037–1042. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
McGranahan N and Swanton C: Clonal
heterogeneity and tumor evolution: Past, present, and the future.
Cell. 168:613–628. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dungrawala H, Bhat KP, Le Meur R, Chazin
WJ, Ding X, Sharan SK, Wessel SR, Sathe AA, Zhao R and Cortez D:
RADX promotes genome stability and modulates chemosensitivity by
regulating RAD51 at replication forks. Mol Cell. 67:374–386.e5.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Juan HC, Lin Y, Chen HR and Fann MJ: Cdk12
is essential for embryonic development and the maintenance of
genomic stability. Cell Death Differ. 23:1038–1048. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mitchem JB, Brennan DJ, Knolhoff BL, Belt
BA, Zhu Y, Sanford DE, Belaygorod L, Carpenter D, Collins L,
Piwnica-Worms D, et al: Targeting tumor-infiltrating macrophages
decreases tumor-initiating cells, relieves immunosuppression, and
improves chemotherapeutic responses. Cancer Res. 73:1128–1141.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Genin M, Clement F, Fattaccioli A, Raes M
and Michiels C: M1 and M2 macrophages derived from THP-1 cells
differentially modulate the response of cancer cells to etoposide.
BMC Cancer. 15:5772015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen Y, Zhu J, Lum PY, Yang X, Pinto S,
MacNeil DJ, Zhang C, Lamb J, Edwards S, Sieberts SK, et al:
Variations in DNA elucidate molecular networks that cause disease.
Nature. 452:429–435. 2008. View Article : Google Scholar : PubMed/NCBI
|
